Comment from Abbvie Inc.
AnonymousOpposeBusiness
Summary: AbbVie Inc. opposes the Alliance for Pharmacy Compounding's petition, arguing that desiccated thyroid extract (DTE) products are biological products that must be licensed via the BLA pathway rather than being eligible for compounding. The company asserts that the classification of DTE as a biological product is a longstanding statutory requirement and urges the FDA to issue guidance prohibiting the illegal compounding of these products.
Please see attachments.